{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:18:16Z","timestamp":1788419896352,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05640-7","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:34:54Z","timestamp":1785137694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High expression of CD74 is associated with poor prognosis and tumor immune infiltration in Acute Myeloid Leukemia"],"prefix":"10.1007","volume":"17","author":[{"given":"Yixi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruotong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"1","key":"5640_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","volume":"14","author":"H Kantarjian","year":"2024","unstructured":"Kantarjian H, Borthakur G, Daver N, et al. Current status and research directions in acute myeloid leukemia. Blood Cancer J. 2024;14(1):163.","journal-title":"Blood Cancer J"},{"issue":"7","key":"5640_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.clml.2025.02.001","volume":"25","author":"V Shah","year":"2025","unstructured":"Shah V, Ravandi F. SOHO State of the Art Updates and Next Questions Acute Myeloid Leukemia: Current Status and Next Questions. Clin Lymphoma Myeloma Leuk. 2025;25(7):465\u201375.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"5640_CR3","doi-asserted-by":"publisher","first-page":"100578","DOI":"10.1016\/j.blre.2019.05.002","volume":"37","author":"P Hansrivijit","year":"2019","unstructured":"Hansrivijit P, Gale RP, Barrett J, Ciurea SO. Cellular therapy for acute myeloid Leukemia \u2013 Current status and future prospects. Blood Rev. 2019;37:100578.","journal-title":"Blood Rev"},{"issue":"6","key":"5640_CR4","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bbamcr.2016.03.026","volume":"1863","author":"B Schr\u00f6der","year":"2016","unstructured":"Schr\u00f6der B. The multifaceted roles of the invariant chain CD74 \u2014 More than just a chaperone. Biochim Biophys Acta BBA - Mol Cell Res. 2016;1863(6):1269\u201381.","journal-title":"Biochim Biophys Acta BBA - Mol Cell Res"},{"issue":"12","key":"5640_CR5","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1369\/jhc.4A6552.2005","volume":"53","author":"CA Barrera","year":"2005","unstructured":"Barrera CA, Beswick EJ, Sierra JC, et al. Polarized Expression of CD74 by Gastric Epithelial Cells. J Histochem Cytochem. 2005;53(12):1481\u20139.","journal-title":"J Histochem Cytochem"},{"issue":"7","key":"5640_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1200\/JCO.2012.45.2177","volume":"31","author":"EC Attar","year":"2013","unstructured":"Attar EC, Johnson JL, Amrein PC, et al. Bortezomib Added to Daunorubicin and Cytarabine During Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients With Previously Untreated Acute Myeloid Leukemia Age 60 to 75 Years: CALGB (Alliance) Study 10502. J Clin Oncol. 2013;31(7):923\u20139.","journal-title":"J Clin Oncol"},{"issue":"33","key":"5640_CR7","doi-asserted-by":"publisher","first-page":"13408","DOI":"10.1073\/pnas.0701553104","volume":"104","author":"I Binsky","year":"2007","unstructured":"Binsky I, Haran M, Starlets D, et al. IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc Natl Acad Sci. 2007;104(33):13408\u201313.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"5640_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1517\/14728222.2011.550879","volume":"15","author":"F Borghese","year":"2011","unstructured":"Borghese F, Clanchy FI. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin Ther Targets. 2011;15(3):237\u201351.","journal-title":"Expert Opin Ther Targets"},{"issue":"19","key":"5640_CR9","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1158\/1078-0432.CCR-04-0182","volume":"10","author":"JD Burton","year":"2004","unstructured":"Burton JD, Ely S, Reddy PK, et al. CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy. Clin Cancer Res. 2004;10(19):6606\u201311.","journal-title":"Clin Cancer Res"},{"issue":"18","key":"5640_CR10","doi-asserted-by":"publisher","first-page":"s5556","DOI":"10.1158\/1078-0432.CCR-07-1167","volume":"13","author":"R Stein","year":"2007","unstructured":"Stein R, Mattes MJ, Cardillo TM, et al. CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms. Clin Cancer Res. 2007;13(18):s5556\u201363.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"5640_CR11","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1182\/blood-2004-03-0890","volume":"104","author":"R Stein","year":"2004","unstructured":"Stein R, Qu Z, Cardillo TM, et al. Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies. Blood. 2004;104(12):3705\u201311.","journal-title":"Blood"},{"issue":"1","key":"5640_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/bjh.14726","volume":"182","author":"M Haran","year":"2018","unstructured":"Haran M, Mirkin V, Braester A, et al. A phase I- II clinical trial of the anti\u2010 CD 74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach. Br J Haematol. 2018;182(1):125\u20138.","journal-title":"Br J Haematol"},{"issue":"6","key":"5640_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1158\/1535-7163.MCT-12-1170","volume":"12","author":"SV Govindan","year":"2013","unstructured":"Govindan SV, Cardillo TM, Sharkey RM, Tat F, Gold DV, Goldenberg DM. Milatuzumab\u2013SN-38 Conjugates for the Treatment of CD74\u2009+\u2009Cancers. Mol Cancer Ther. 2013;12(6):968\u201378.","journal-title":"Mol Cancer Ther"},{"issue":"16","key":"5640_CR14","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1182\/blood-2011-09-381988","volume":"119","author":"P Gupta","year":"2012","unstructured":"Gupta P, Goldenberg DM, Rossi EA, et al. Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20\/CD74 bispecific antibodies in mantle cell and other lymphomas. Blood. 2012;119(16):3767\u201378.","journal-title":"Blood"},{"issue":"19","key":"5640_CR15","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.3390\/cancers13195012","volume":"13","author":"K Wurster","year":"2021","unstructured":"Wurster K, Costanza M, Kreher S, et al. Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL). Cancers. 2021;13(19):5012.","journal-title":"Cancers"},{"issue":"9","key":"5640_CR16","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/bloodadvances.2022008303","volume":"7","author":"Q Le","year":"2023","unstructured":"Le Q, Tang T, Leonti A, et al. Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia. Blood Adv. 2023;7(9):1666\u201370.","journal-title":"Blood Adv"},{"issue":"6","key":"5640_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"issue":"W1","key":"5640_CR18","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"5640_CR19","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"issue":"D1","key":"5640_CR20","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein\u2013protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"5640_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-2003-39374","volume":"215","author":"Anon","year":"2003","unstructured":"Anon. Analyse der Ursachen von Todesf\u00e4llen im Verlauf der intensiven Anfangschemotherapie in der Studie AML-BFM 93. Klin P\u00e4diatr. 2003;215(3):151\u20138.","journal-title":"Klin P\u00e4diatr"},{"issue":"1","key":"5640_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40364-024-00649-y","volume":"12","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Huang G, Cai X, Liu Y, Qian B, Li D. Global, regional, and national burden of acute myeloid leukemia, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Biomark Res. 2024;12(1):101.","journal-title":"Biomark Res"},{"issue":"10","key":"5640_CR23","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.3324\/haematol.2023.283757","volume":"109","author":"AJ Menssen","year":"2024","unstructured":"Menssen AJ, Hudson CA, Alonzo T, et al. CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children\u2019s Oncology Group. Haematologica. 2024;109(10):3182\u201393.","journal-title":"Haematologica"},{"key":"5640_CR24","doi-asserted-by":"publisher","first-page":"1770711","DOI":"10.3389\/fimmu.2026.1770711","volume":"17","author":"Y Wang","year":"2026","unstructured":"Wang Y, Zhang Y, Li Y, et al. The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification. Front Immunol. 2026;17:1770711.","journal-title":"Front Immunol"},{"key":"5640_CR25","first-page":"1439","volume":"17","author":"Y Gou","year":"2025","unstructured":"Gou Y, Li Y, Wang Y, et al. Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker. Breast Cancer. 2025;17:1439\u201361.","journal-title":"Breast Cancer"},{"key":"5640_CR26","doi-asserted-by":"publisher","first-page":"1667589","DOI":"10.3389\/fonc.2025.1667589","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Wang Y, Ma H, et al. CLIC6\u2019s role in cancer: from broad analysis to breast cancer validation. Front Oncol. 2025;15:1667589.","journal-title":"Front Oncol"},{"key":"5640_CR27","doi-asserted-by":"publisher","first-page":"1670526","DOI":"10.3389\/fonc.2025.1670526","volume":"15","author":"D Elihamu","year":"2025","unstructured":"Elihamu D, Li Y, Wang Y, et al. CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation. Front Oncol. 2025;15:1670526.","journal-title":"Front Oncol"},{"issue":"1","key":"5640_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1182\/blood-2007-10-119438","volume":"113","author":"SM Kornblau","year":"2009","unstructured":"Kornblau SM, Tibes R, Qiu YH, et al. Functional proteomic profiling of AML predicts response and survival. Blood. 2009;113(1):154\u201364.","journal-title":"Blood"},{"issue":"4","key":"5640_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976;33(4):451\u20138.","journal-title":"Br J Haematol"},{"key":"5640_CR30","doi-asserted-by":"publisher","first-page":"1790936","DOI":"10.3389\/fimmu.2026.1790936","volume":"17","author":"Z Liu","year":"2026","unstructured":"Liu Z, Liu J, Chu H, et al. JAK inhibition in PD-1 immunotherapy and tumor microenvironment. Front Immunol. 2026;17:1790936.","journal-title":"Front Immunol"},{"key":"5640_CR31","doi-asserted-by":"publisher","first-page":"1678907","DOI":"10.3389\/fimmu.2025.1678907","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lu K, Xu Y, Xu S, Chu H, Fang X. Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies. Front Immunol. 2025;16:1678907.","journal-title":"Front Immunol"},{"key":"5640_CR32","doi-asserted-by":"crossref","unstructured":"Wang P, Xu S, Guo Q, Zhao Y. Discovery of PAK2 as a key regulator of cancer stem cell in head and neck squamous cell carcinoma using multi-omic techniques. Stem Cells Int 2025; 2025:1325262.","DOI":"10.1155\/sci\/1325262"},{"key":"5640_CR33","doi-asserted-by":"publisher","first-page":"1636839","DOI":"10.3389\/fimmu.2025.1636839","volume":"16","author":"RA Youness","year":"2025","unstructured":"Youness RA, Elemam NM, Abdelhamid AM, et al. Macrophage migration inhibitory factor (MIF) and the tumor ecosystem: a tale of inflammation, immune escape, and tumor growth. Front Immunol. 2025;16:1636839.","journal-title":"Front Immunol"},{"issue":"4","key":"5640_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5590","volume":"56","author":"G Camacho Meza","year":"2025","unstructured":"Camacho Meza G, Avalos Navarro G, De La Cruz Mosso U, Ram\u00edrez Pati\u00f1o R, Mu\u00f1oz Valle J, Bautista Herrera L. Macrophage migration inhibitory factor: Exploring physiological roles and comparing health benefits against oncogenic and autoimmune risks (Review). Int J Mol Med. 2025;56(4):1\u201321.","journal-title":"Int J Mol Med"},{"issue":"11","key":"5640_CR35","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.20030286","volume":"197","author":"L Leng","year":"2003","unstructured":"Leng L, Metz CN, Fang Y, et al. MIF Signal Transduction Initiated by Binding to CD74. J Exp Med. 2003;197(11):1467\u201376.","journal-title":"J Exp Med"},{"issue":"1","key":"5640_CR36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00018-024-05338-5","volume":"81","author":"L Zhang","year":"2024","unstructured":"Zhang L, Woltering I, Holzner M, et al. CD74 is a functional MIF receptor on activated CD4\u2009+\u2009T cells. Cell Mol Life Sci. 2024;81(1):296.","journal-title":"Cell Mol Life Sci"},{"issue":"22","key":"5640_CR37","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1182\/blood.V114.22.1616.1616","volume":"114","author":"EC Attar","year":"2009","unstructured":"Attar EC, Maharry K, Mr\u00f3zek K, et al. Increased Expression of Macrophage Migration Inhibitory Factor (MIF) Receptor CD74 Is Associated with Inferior Outcome in Younger Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML): a Cancer and Leukemia Group B (CALGB) Study. Blood. 2009;114(22):1616\u20131616.","journal-title":"Blood"},{"key":"5640_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ebiom.2019.05.025","volume":"44","author":"PP Ruvolo","year":"2019","unstructured":"Ruvolo PP, Hu CW, Qiu Y, et al. LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML. eBioMedicine. 2019;44:126\u201337.","journal-title":"eBioMedicine"},{"key":"5640_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ebiom.2019.05.051","volume":"44","author":"IM Yasinska","year":"2019","unstructured":"Yasinska IM, Sumbayev VV. Alliance of galectin-3 and CD74 biochemical networks as a crucial component of survival machinery operated by human acute myeloid leukaemia cells. eBioMedicine. 2019;44:2\u20133.","journal-title":"eBioMedicine"},{"issue":"11","key":"5640_CR40","doi-asserted-by":"publisher","first-page":"e13277","DOI":"10.1002\/advs.202513277","volume":"13","author":"Y Lei","year":"2026","unstructured":"Lei Y, Wang X, Liu J, et al. WDR5-H3K4me3 Epigenetic Axis Promotes TRMT6\u2010Dependent tRNA M1 A Modification to Facilitate Triple\u2010Negative Breast Cancer Progression by Suppressing Ferroptosis. Adv Sci. 2026;13(11):e13277.","journal-title":"Adv Sci"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05640-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:07:06Z","timestamp":1788419226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05640-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5640"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05640-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to the publication of all contents within this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1294"}}